
A company that assesses DNA is dealing with the repercussions of public outcry after a data protection lawyer highlighted a …

The genetic testing firm 23andMe is seeking to raise $150 million in order to move into its own drug development …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

